EyeGate Pharmaceuticals, Inc. has announced that the United States Patent and Trademark Office (USPTO) has issued the Company a patent covering the utility of its iontophoretic contact lens. The U.S. patent entitled “Iontophoretic Contact Lens” was issued on the 10th April, 2018. “The issuance of this new patent represents a significant milestone in the development of our proprietary iontophoretic contact lens,” said ...